| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFF4
|
AF4/FMR2 family, member 4
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGR2
|
anterior gradient 2
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKIP1
|
A kinase (PRKA) interacting protein 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APC
|
adenomatous polyposis coli
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ARHGAP26
|
Rho GTPase activating protein 26
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
|
ASXL2
|
additional sex combs like transcriptional regulator 2
|
|
ATF1
|
activating transcription factor 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AXIN1
|
axin 1
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BCAS3
|
breast carcinoma amplified sequence 3
|
|
BCAS4
|
breast carcinoma amplified sequence 4
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL9
|
B-cell CLL/lymphoma 9
|
|
BCR
|
breakpoint cluster region
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRCC3
|
BRCA1/BRCA2-containing complex, subunit 3
|
|
BRD7
|
bromodomain containing 7
|
|
BRI3BP
|
BRI3 binding protein
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRMS1
|
breast cancer metastasis suppressor 1
|
|
BTG1
|
B-cell translocation gene 1, anti-proliferative
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CALR
|
calreticulin
|
|
CARS
|
cysteinyl-tRNA synthetase
|
|
CBFB
|
core-binding factor, beta subunit
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCND1
|
cyclin D1
|
|
CCNL1
|
cyclin L1
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHEK2
|
checkpoint kinase 2
|
|
CMC4
|
C-x(9)-C motif containing 4
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAB2IP
|
DAB2 interacting protein
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6
|
|
DEK
|
DEK proto-oncogene
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNAJC27
|
DnaJ (Hsp40) homolog, subfamily C, member 27
|
|
DOCK4
|
dedicator of cytokinesis 4
|
|
ECT2
|
epithelial cell transforming 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAC2
|
elaC ribonuclease Z 2
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ELL
|
elongation factor RNA polymerase II
|
|
ENTPD5
|
ectonucleoside triphosphate diphosphohydrolase 5
|
|
EPHB2
|
EPH receptor B2
|
|
EPS15
|
epidermal growth factor receptor pathway substrate 15
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
ETV1
|
ets variant 1
|
|
ETV4
|
ets variant 4
|
|
ETV6
|
ets variant 6
|
|
EVI2A
|
ecotropic viral integration site 2A
|
|
EVI2B
|
ecotropic viral integration site 2B
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
FAM126A
|
family with sequence similarity 126, member A
|
|
FAM3C
|
family with sequence similarity 3, member C
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FER
|
fer (fps/fes related) tyrosine kinase
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGF6
|
fibroblast growth factor 6
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FOXP1
|
forkhead box P1
|
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas 1
|
|
FRK
|
fyn-related Src family tyrosine kinase
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
FUS
|
FUS RNA binding protein
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GAS7
|
growth arrest-specific 7
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
|
GLI1
|
GLI family zinc finger 1
|
|
GMPS
|
guanine monphosphate synthase
|
|
GNAS
|
GNAS complex locus
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HLF
|
hepatic leukemia factor
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HOPX
|
HOP homeobox
|
|
HOXA9
|
homeobox A9
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IL2
|
interleukin 2
|
|
ING1
|
inhibitor of growth family, member 1
|
|
ING4
|
inhibitor of growth family, member 4
|
|
IRF1
|
interferon regulatory factor 1
|
|
JAK2
|
Janus kinase 2
|
|
JAZF1
|
JAZF zinc finger 1
|
|
JUN
|
jun proto-oncogene
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KCTD11
|
potassium channel tetramerization domain containing 11
|
|
KDSR
|
3-ketodihydrosphingosine reductase
|
|
KIF1B
|
kinesin family member 1B
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LETMD1
|
LETM1 domain containing 1
|
|
LGR6
|
leucine-rich repeat containing G protein-coupled receptor 6
|
|
LHX4
|
LIM homeobox 4
|
|
LIMD1
|
LIM domains containing 1
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LMO1
|
LIM domain only 1 (rhombotin 1)
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LYL1
|
lymphoblastic leukemia associated hematopoiesis regulator 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAS1
|
MAS1 proto-oncogene, G protein-coupled receptor
|
|
MCC
|
mutated in colorectal cancers
|
|
MCF2
|
MCF.2 cell line derived transforming sequence
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDS2
|
myelodysplastic syndrome 2 translocation associated
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLLT1
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1
|
|
MLLT10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10
|
|
MLLT11
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11
|
|
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3
|
|
MLLT4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4
|
|
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6
|
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MTCP1
|
mature T-cell proliferation 1
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
NBN
|
nibrin
|
|
NCKIPSD
|
NCK interacting protein with SH3 domain
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NDRG2
|
NDRG family member 2
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NEURL1
|
neuralized E3 ubiquitin protein ligase 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NUP214
|
nucleoporin 214kDa
|
|
OLIG2
|
oligodendrocyte lineage transcription factor 2
|
|
PAF1
|
Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae)
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PARK7
|
parkinson protein 7
|
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1
|
|
PAX3
|
paired box 3
|
|
PAX5
|
paired box 5
|
|
PAX7
|
paired box 7
|
|
PBX1
|
pre-B-cell leukemia homeobox 1
|
|
PCM1
|
pericentriolar material 1
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PHB
|
prohibitin
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
|
PML
|
promyelocytic leukemia
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
PRCC
|
papillary renal cell carcinoma (translocation-associated)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCI
|
protein kinase C, iota
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PTTG3P
|
pituitary tumor-transforming 3, pseudogene
|
|
RAB8A
|
RAB8A, member RAS oncogene family
|
|
RAB8B
|
RAB8B, member RAS oncogene family
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RB1
|
retinoblastoma 1
|
|
RBM15
|
RNA binding motif protein 15
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RET
|
ret proto-oncogene
|
|
RHOA
|
ras homolog family member A
|
|
RNF213
|
ring finger protein 213
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2
|
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
|
SET
|
SET nuclear proto-oncogene
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
SIRT4
|
sirtuin 4
|
|
SKI
|
SKI proto-oncogene
|
|
SPECC1
|
sperm antigen with calponin homology and coiled-coil domains 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
SSX2B
|
synovial sarcoma, X breakpoint 2B
|
|
STIL
|
SCL/TAL1 interrupting locus
|
|
STK11
|
serine/threonine kinase 11
|
|
STYK1
|
serine/threonine/tyrosine kinase 1
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
T
|
T, brachyury homolog (mouse)
|
|
TAF15
|
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TAL2
|
T-cell acute lymphocytic leukemia 2
|
|
TBC1D3
|
TBC1 domain family, member 3
|
|
TBC1D3B
|
TBC1 domain family, member 3B
|
|
TBC1D3F
|
TBC1 domain family, member 3F
|
|
TBRG1
|
transforming growth factor beta regulator 1
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCTA
|
T-cell leukemia translocation altered
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
|
TFG
|
TRK-fused gene
|
|
TFPT
|
TCF3 (E2A) fusion partner (in childhood Leukemia)
|
|
THPO
|
thrombopoietin
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TPM3
|
tropomyosin 3
|
|
TPR
|
translocated promoter region, nuclear basket protein
|
|
TRIM24
|
tripartite motif containing 24
|
|
TRIM27
|
tripartite motif containing 27
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UFL1
|
UFM1-specific ligase 1
|
|
URI1
|
URI1, prefoldin-like chaperone
|
|
USP4
|
ubiquitin specific peptidase 4 (proto-oncogene)
|
|
USP6
|
ubiquitin specific peptidase 6
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WDR11
|
WD repeat domain 11
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1
|
|
WISP1
|
WNT1 inducible signaling pathway protein 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
XAF1
|
XIAP associated factor 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB7C
|
zinc finger and BTB domain containing 7C
|
|
ZDHHC17
|
zinc finger, DHHC-type containing 17
|
|
ZFYVE19
|
zinc finger, FYVE domain containing 19
|
|
ZMYND11
|
zinc finger, MYND-type containing 11
|
|
ZNF320
|
zinc finger protein 320
|
|
ZNF521
|
zinc finger protein 521
|
